MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with D

Dapoxetine

Dapoxetine 30mg tablets

No stability information

Stability notes for Dapoxetine 30mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Dapoxetine 30mg tablets
Dapoxetine 30mg tablets (A A H Pharmaceuticals Ltd)
Dapoxetine 30mg tablets (Alliance Healthcare (Distribution) Ltd)
Dapoxetine 30mg tablets (Consilient Health Ltd)
Priligy 30mg tablets (Phoenix Labs Ltd)

Dapoxetine 60mg tablets

No stability information

Stability notes for Dapoxetine 60mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Dapoxetine 60mg tablets
Dapoxetine 60mg tablets (A A H Pharmaceuticals Ltd)
Dapoxetine 60mg tablets (Alliance Healthcare (Distribution) Ltd)
Dapoxetine 60mg tablets (Consilient Health Ltd)
Priligy 60mg tablets (Phoenix Labs Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.